CN111066991A - Preparation method of composite prebiotics solid beverage for improving gastrointestinal tract function - Google Patents
Preparation method of composite prebiotics solid beverage for improving gastrointestinal tract function Download PDFInfo
- Publication number
- CN111066991A CN111066991A CN201911423148.5A CN201911423148A CN111066991A CN 111066991 A CN111066991 A CN 111066991A CN 201911423148 A CN201911423148 A CN 201911423148A CN 111066991 A CN111066991 A CN 111066991A
- Authority
- CN
- China
- Prior art keywords
- oligosaccharide
- solid beverage
- preparation
- composite
- protein peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 60
- 239000007787 solid Substances 0.000 title claims abstract description 60
- 239000002131 composite material Substances 0.000 title claims abstract description 50
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 21
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 19
- 229920001202 Inulin Polymers 0.000 claims abstract description 18
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 18
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 18
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 18
- 229940029339 inulin Drugs 0.000 claims abstract description 18
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 17
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 17
- 235000009566 rice Nutrition 0.000 claims abstract description 17
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 16
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 16
- 102000008186 Collagen Human genes 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 15
- 241000283690 Bos taurus Species 0.000 claims abstract description 14
- 239000004386 Erythritol Substances 0.000 claims abstract description 13
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920001436 collagen Polymers 0.000 claims abstract description 13
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 13
- 235000019414 erythritol Nutrition 0.000 claims abstract description 13
- 229940009714 erythritol Drugs 0.000 claims abstract description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000832 lactitol Substances 0.000 claims abstract description 11
- 235000010448 lactitol Nutrition 0.000 claims abstract description 11
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims abstract description 11
- 229960003451 lactitol Drugs 0.000 claims abstract description 11
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000811 xylitol Substances 0.000 claims abstract description 11
- 235000010447 xylitol Nutrition 0.000 claims abstract description 11
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 11
- 229960002675 xylitol Drugs 0.000 claims abstract description 11
- 241000209094 Oryza Species 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 150000005846 sugar alcohols Chemical class 0.000 claims description 10
- 238000005469 granulation Methods 0.000 claims description 7
- 230000003179 granulation Effects 0.000 claims description 7
- 208000001132 Osteoporosis Diseases 0.000 claims description 3
- 229920001503 Glucan Polymers 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 230000007661 gastrointestinal function Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 abstract description 9
- 239000002245 particle Substances 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 8
- 230000001055 chewing effect Effects 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 description 38
- 238000011156 evaluation Methods 0.000 description 19
- 230000001953 sensory effect Effects 0.000 description 19
- 241000186016 Bifidobacterium bifidum Species 0.000 description 12
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000005303 weighing Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000006041 probiotic Substances 0.000 description 9
- 235000018291 probiotics Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000282414 Homo sapiens Species 0.000 description 8
- 244000199866 Lactobacillus casei Species 0.000 description 8
- 235000013958 Lactobacillus casei Nutrition 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 229940017800 lactobacillus casei Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 238000009630 liquid culture Methods 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 241000186000 Bifidobacterium Species 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000002655 kraft paper Substances 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000006872 mrs medium Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- -1 Citric acid diamine Chemical class 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 229910052564 epsomite Inorganic materials 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- XFIKMPRBSORKQP-JATHGWPISA-M lithium;9-[(e)-4-[(2s,3r,4r,5s)-3,4-dihydroxy-5-[[(2s,3s)-3-[(2s,3s)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate Chemical class [Li+].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 XFIKMPRBSORKQP-JATHGWPISA-M 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 235000019607 umami taste sensations Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a preparation method of a composite prebiotics solid beverage for improving gastrointestinal tract function, and belongs to the technical field of food processing. Finally determining malt extract, bovine bone collagen peptide, yeast powder, lactitol, xylitol, erythritol, inulin, xylo-oligosaccharide, fructo-oligosaccharide, galacto-oligosaccharide and rice protein peptide by adjusting the adding amount of each component in the composite solid beverage and the particle size of the composite solid beverage, wherein the mass ratio of the malt extract to the bovine bone collagen peptide to the yeast powder is 25: 15: 10: 7: 7: 7: 6: 6: 6: 6: 5, the mouthfeel is optimal; the particle size of 30-40 meshes is selected to avoid choking when eating, and reduce the peculiar smell in the oral cavity by chewing.
Description
Technical Field
The invention relates to a preparation method of a composite prebiotics solid beverage for improving gastrointestinal tract function, belonging to the technical field of food processing.
Technical Field
With the change of times development, social requirements and disease spectrum, the health concept of human beings is more comprehensive, the idea of health of people is changed from a single mode of completely depending on medicines after illness treatment to a full-range integrated mode of prevention, treatment and maintenance, and the serious threats of diet, medicines, living environment and the like to the health of human bodies are relieved. The probiotics is widely applied to the processes of disease prevention, treatment, disease repair and the like by virtue of the characteristics of safety, reliability, excellent performance and the like. While prebiotics are well known to the public, the concept and effect of prebiotics is not fully understood.
Prebiotics, as a food ingredient that is not readily digestible, while not being broken down by enzymes in the host, beneficially affect the host by selectively stimulating the growth and activity of the gut microbiota. As a "Food" for providing nutrition to probiotics, Prebiotics are able to promote the growth and reproduction of both endogenous and exogenous probiotics, achieve the effects of preventing diarrhea or constipation, regulating gut flora metabolism, promoting lipid metabolism, stimulating mineral adsorption and immunomodulatory properties (Michael de Vrese & J. schrezenmeir. probiotics, and probiotics [ J ]. Food Biotechnology,2008 (111): 1-66.). In addition, compared with exogenous probiotics, the prebiotics can better adapt to the ecological environment of the gastrointestinal tract and provide nutrition for intestinal probiotics of any type; and has rich source, low cost and low storage condition. However, in the market today, prebiotic products are few, single in ingredient, not obvious in effect and high in price. In addition, a plurality of prebiotics are limited, such as 3g of xylo-oligosaccharide for daily use, 15g of galacto-oligosaccharide for daily use, and 15g of inulin for daily use, and if the prebiotics are eaten in excess, adverse reactions such as diarrhea can be caused. Therefore, the development of a compound solid beverage containing abundant prebiotics is urgently needed.
Disclosure of Invention
In order to solve the problems, the invention provides a composite solid beverage, which comprises malt extract, bovine bone collagen peptide, rice protein peptide, yeast powder, lactitol, xylitol, erythritol, inulin, xylo-oligosaccharide, fructo-oligosaccharide and galacto-oligosaccharide, and has the function of improving the gastrointestinal tract function.
The first purpose of the invention is to provide a preparation method of a composite prebiotics solid beverage, which takes malt extract, protein peptide, sugar alcohol and prebiotics as raw materials, and the raw materials are mixed and granulated to obtain the composite solid beverage; the mass ratio of the malt extract to the protein peptide to the sugar alcohol to the prebiotics is 5: (3-5): (4-6): (4-6).
In one embodiment of the invention, the granulation temperature is 40-50 ℃.
In one embodiment of the present invention, the malt extract is a pure natural nutrient rich in maltose, fructose, amino acids, small molecule peptides, various vitamins, trace elements, and various growth promoting factors extracted from barley and malt by enzymatic hydrolysis. The malt extract is added in a certain amount, so that the product has certain malt fragrance.
In one embodiment of the present invention, the protein peptide is a mixture of bovine bone collagen peptide and rice protein peptide. The bovine bone collagen peptide (enzymolysis bone powder) is prepared by taking bones as raw materials through the procedures of cleaning, degreasing, enzymolysis, drying, superfine grinding and the like, and the collagen peptide which retains nutrient substances in the bones to a great extent can better promote the growth of bone cells and prevent osteoporosis of human bodies.
The rice protein peptide is an amino acid polymer taking rice protein as a raw material. The molecular weight of the substance is smaller than that of protein, the structure is simple, and the physiological activity is strong. It can be directly absorbed in the proximal small intestine without digestion, and does not consume energy. As an active protein, the rice protein peptide is easier to digest and absorb by human bodies, has the functions of reducing blood pressure, blood fat and cholesterol, resisting bacteria and resisting oxidation, is used as a functional protein additive, and is widely applied to the fields of health-care food, nutritional food and the like.
In one embodiment of the invention, the sugar alcohol is one or more of lactitol, xylitol, erythritol. The erythritol is a low-calorie sweetener, has cool mouthfeel, is instantly melted in the mouth, has good tolerance and anti-dental caries, has no toxic effect, and is widely used for producing various foods; does not participate in sugar metabolism and blood sugar change, and prevents hyperglycemia, so erythritol is a useful and safe food ingredient for diabetic patients; in addition, erythritol acts as an antioxidant, reducing hyperglycemia and reducing oxidative stress.
The xylitol does not need insulin to participate in the metabolism in vivo, does not increase the blood sugar value, can be used as a sweetener and a nutritional supplement for a diabetic, has low calorie, prevents decayed teeth, and is widely applied to the fields of foods such as desserts, milk and the like.
The lactitol has good thermal stability and acid-base stability, mild action and no side effect, and is an effective proliferation factor of probiotics.
In one embodiment of the invention, the sugar alcohol is one or more of inulin, fructo-oligosaccharide, xylo-oligosaccharide and galacto-oligosaccharide. The inulin is a naturally-occurring non-structural storage carbohydrate, has heat lower than that of a common carbohydrate, cannot be digested by digestive enzymes of a human body, can accelerate fat consumption and increase satiety, and can be fermented in the large intestine of the human body to generate beneficial bacteria to improve the gastrointestinal health.
The fructo-oligosaccharide is a water-soluble dietary fiber, can reduce serum cholesterol and improve lipid metabolism after long-term administration, and has obvious proliferation effect on beneficial bacteria in intestinal tract such as Bacillus bifidus.
The xylo-oligosaccharide is a food supplement with good stability, is one of varieties with the strongest functions of proliferating bifidobacteria in polymerized saccharides, and achieves the effect of improving the gastrointestinal health by reducing the pH of intestinal tracts, inhibiting the growth of harmful bacteria and promoting the proliferation of beneficial bacteria.
The galacto-oligosaccharide is a functional oligosaccharide which can proliferate bifidobacterium with high selectivity, improve protein absorption and relax bowel.
In one embodiment of the present invention, the raw material further comprises yeast powder, which is a natural flavor enhancer that provides organic nitrogen source and nutrients such as vitamins, growth factors, etc. to the microorganisms.
In one embodiment of the invention, the mass ratio of the malt extract, the bovine bone collagen peptide, the yeast powder, the lactitol, the xylitol, the erythritol, the inulin, the xylo-oligosaccharide, the fructo-oligosaccharide, the galacto-oligosaccharide and the rice protein peptide is (5-50): (5-30): (6-30): (4-7.5): (4-10): (5-10): (5-8): (5.5-7): (5-7.5): (5-7.5): (5-11).
In one embodiment of the present invention, the mass ratio of the malt extract, bovine bone collagen peptide, yeast powder, lactitol, xylitol, erythritol, inulin, xylooligosaccharide, fructooligosaccharide, galactooligosaccharide and rice protein peptide is 25: 15: 10: 7: 7: 7: 6: 6: 6: 6: 5.
in one embodiment of the invention, the granulation is performed at 50 ℃ so that the particle size of the composite solid beverage is 30-40 meshes.
The second purpose of the invention is to provide a composite prebiotic solid beverage prepared by the method.
The third purpose of the invention is to provide the application of the composite prebiotics solid beverage in improving the gastrointestinal tract function and preventing osteoporosis of human body.
The invention has the beneficial effects that:
1. the composite prebiotics solid beverage prepared by the method is rich in nutrition, effectively proliferates beneficial intestinal microorganisms and regulates the microbial ecological balance.
2. The invention adopts protein peptide, sugar alcohol and malt extract as a plurality of auxiliary materials to be compounded with prebiotics, so that the prebiotics solid beverage has a plurality of efficacies, can improve the positive effects and influences of the prebiotics on constipation improvement, gastrectasia and dyspepsia alleviation, and can effectively prevent adverse reactions such as diarrhea caused by excessive consumption.
3. The invention finally determines malt extract, bovine bone collagen protein peptide, yeast powder Angel YP101, lactitol, xylitol, erythritol, inulin, xylo-oligosaccharide, fructo-oligosaccharide, galacto-oligosaccharide and rice protein peptide, wherein the mass ratio is 25: 15: 10: 7: 7: 7: 6: 6: 6: 6: 5, the mouthfeel is optimal; when the oral liquid is taken, the particle size of 30-40 meshes is selected, so that choking and cough can be avoided when the oral liquid is taken, and peculiar smell in the oral cavity can be reduced through chewing.
Drawings
FIG. 1: and (3) granulating the mixture to obtain 20-30 meshes, 30-40 meshes and more than 40 meshes of composite solid beverage.
FIG. 2: and (4) evaluating the functions of the compound solid beverage.
Detailed Description
The yeast powder and yeast extract of various types related in the following examples are purchased from Angel Yeast GmbH; bovine bone collagen peptides referred to in the examples below were purchased from henan grazing biotechnology; the malt extracts referred to in the following examples were purchased from deodour biotechnology (shanghai) ltd; inulin, referred to in the following examples, was purchased from Shanghai Fuxin industries, Inc.; xylo-oligosaccharide and xylitol related in the following examples were purchased from Shandong Longli Biotech GmbH; erythritol and galacto-oligosaccharides referred to in the following examples were purchased from shin-chang bio-corporation; lactitol referred to in the following examples was purchased from Shandong Lvjian Biotechnology Ltd; the rice protein peptides referred to in the following examples were purchased from Wuxi Jinnong Biotech, Inc.; the components of the medium described in the following examples were all collected from the national pharmaceutical products chemical Co.
The detection methods referred to in the following examples are as follows:
1. sensory evaluation: taking a compound solid beverage sample, placing the compound solid beverage sample in a tasting cup, and carrying out the sampling in 100 people;
sensory evaluation criteria:
2. and (3) evaluating the solubility: the reconstituted sample was taken and placed in a taste cup and the sample solubility was observed.
Solubility scoring criteria: the solubility score is 1-5, 1: substantially insoluble, very insoluble in the presence of 2: partially dissolved, more insoluble material present, 3: the solvent is easy to dissolve, less insoluble substances exist, and the content is 4-5 min: is very soluble and almost has no insoluble matter.
3. Strain activation and counting:
because the bacterial strains for regulating the intestinal probiotic groups are mainly bifidobacterium and lactobacillus, a bifidobacterium and a lactobacillus are selected for in-vitro tests, and the bifidobacterium and the lactobacillus are bifidobacterium bifidum and lactobacillus casei; the preservation number of the bifidobacterium bifidum is CGMCC NO. 13632; the preservation number of the lactobacillus casei is CCTCC NO: m207107. The in vitro test comprises the steps of culturing bifidobacterium bifidum by using an MRS-mupirocin lithium salt improved culture medium, culturing lactobacillus casei by using the MRS culture medium, and counting.
The specific steps of strain activation are as follows: using a pipette gun to suck 30 mu L of bacteria-retaining tube bacterial liquid and injecting the liquid into a 1.5mL sterile centrifuge tube containing 0.7mL liquid culture medium (using MRS-mupirocin lithium salt modified liquid culture medium to culture bifidobacterium bifidum, using MRS culture medium to culture lactobacillus casei), and culturing for 24h, which is one generation activation; then, sucking 200 mu L of culture medium containing the first generation of activated strain, injecting the culture medium into 5mL of the same sterile standard culture medium, and culturing for 12h, wherein the second generation of activation is; the consumable materials used by the activated strain are as follows: 1.5mL centrifuge tube, sterile standard culture medium, 200 muL pipette and 200 muL pipette tip; the MRS culture medium has the following formula:
composition (I) | g/L |
Peptone (Soybean or fish meal) | 10 |
|
10 |
|
20 |
Sodium acetate | 5 |
Yeast extract | 5 |
Citric acid diamine | 2 |
K2HPO4 | 2 |
MgSO4·7H2O | 0.1 |
MnSO4·H2O | 0.05 |
Tween 80 | 1mL |
After weighing, adding pure water, and stirring on a magnetic stirrer. After stirring uniformly, 5mL of liquid culture medium of LMRS is subpackaged in each test tube by a 5mL pipette, a plug is plugged, the test tube is bound by kraft paper, and the test tube is marked and sterilized (121 ℃, 15 min).
The MRS-mupirocin lithium salt modified liquid culture medium is prepared by adding mupirocin lithium salt (5 mg/piece, each piece is added to 100ml of MRS culture medium) and pure water after the MRS culture medium is weighed, and stirring on a magnetic stirrer. After stirring evenly, 5mL of the improved liquid culture medium of 5mL of RS-mupirocin lithium salt is subpackaged in each test tube by a pipette gun, a plug is plugged, the test tube is bound by kraft paper, and the test tube is marked and sterilized (121 ℃, 15 min).
The MRS agar culture medium comprises: the same weighing method as the MRS liquid culture medium is adopted for operation, purified water is added after the weighing is finished, and the mixture is stirred on a magnetic stirrer. Adding agar into the flask in advance at a content of 1.5-1.8% according to the planned culture medium volume of each triangular flask, stirring culture medium uniformly, subpackaging according to the planned loading amount of each flask, covering with a stopper, wrapping with kraft paper, labeling, and sterilizing (121 deg.C, 15 min).
The MRS-mupirocin lithium salt modified agar culture medium comprises: the same weighing method as that of the MRS-mupirocin lithium salt modified liquid medium is adopted for operation, and purified water is added after the weighing is finished, and the mixture is stirred on a magnetic stirrer. Adding agar into the flask in advance at a content of 1.5-1.8% according to the planned culture medium volume of each triangular flask, stirring culture medium uniformly, subpackaging according to the planned loading amount of each flask, covering with a stopper, wrapping with kraft paper, labeling, and sterilizing (121 deg.C, 15 min).
The viable bacteria counting method comprises the following specific steps: 0.5mL of culture medium liquid is sucked by a 1mL sterile sucker or a micropipette, slowly injected into a sterile test tube containing 4.5mL of physiological saline along the tube wall, and uniformly mixed by a vortex mixer to prepare a 1:10 sample uniform liquid. According to the above operation proceduresRepeating the steps once to prepare 1:100 sample homogenizing liquid. And so on. Each incremental dilution was replaced with 1mL sterile pipette or tip. Selection 10-6、10-7、10-8Three gradients. The highest gradient dilution of 1mL of sample was pipetted into a pre-numbered sterile plate, and 3 plates were made for each dilution. And (3) pouring 15-20 mL of plate counting agar culture medium (which can be placed in a thermostatic water bath box at 46 +/-1 ℃ for heat preservation and can be used for testing the temperature by hand back) cooled to 46 ℃ into the plate in time, and rotating the plate three times clockwise and three times anticlockwise to uniformly mix the plate. After the agar is solidified, the plate is turned over and cultured for 48 plus or minus 2h at 36 plus or minus 1 ℃ (bifidobacterium bifidum is cultured in an anaerobic way and lactobacillus is cultured in a normal condition). Colony counts are expressed in Colony Forming Units (CFU). And selecting a plate with the colony number of 30-300 CFU and no spread colony growth to count the total number of the colonies.
Example 1: preparation of composite solid beverage
The method comprises the following specific steps:
(1) weighing raw materials of the composite solid beverage according to the table 1, and fully mixing by using a mixer;
(2) and (3) granulation: the granulation temperature is 50 ℃, and a sample is obtained by sieving through a 40-mesh sieve; part of the obtained composite solid beverage samples were taken and subjected to sensory evaluation, and the evaluation results are shown in table 2.
TABLE 1 recipe (g/100g) of composite solid beverage for each group
TABLE 2 sensory evaluation of the composite solid beverages of each group
Group of | Scoring |
Group 1 | 27.8 |
Group 2 | 24 |
Group 3 | 20.6 |
Group 4 | 20 |
Group 5 | 21.6 |
Group 6 | 14 |
Group 7 | 18 |
Group 8 | 19 |
Note: each sensory score in the table is an average of 100 human scores.
As can be seen from table 2, the composite solid beverage sample of group 1 was just melted in the mouth, had good flavor and mouthfeel, and had a sensory evaluation of 27.8 in 100 persons, which was at a level of liking close to being very liking; the composite solid beverage sample of group 2 dissolved immediately upon entry, was slightly bitter, and the sensory evaluation result of 100 persons was 24, which was at a favorable level; the compound solid beverage sample of group 3 dissolved immediately after being taken into the mouth, the bitterness was slightly heavy, and the sensory evaluation result of 100 persons was 20.6, which is at a level not particularly preferred; the compound solid beverage sample of group 4 had a light yeast powder taste with a slight umami taste, and the sensory evaluation result of 100 persons was 20, which was at a level not unpleasant nor preferred; the compound solid beverage sample of group 5, with bitter taste, had a sensory rating of 21.6 for 100 persons, at a dislike level; the composite solid beverage sample of group 6, which was the most bitter than the other samples, had a sensory rating of 14 in 100 persons, at an annoying level; in the compound solid beverage sample of the group 7, the yeast powder has heavier taste and more obvious delicate flavor, and 100 people have 18 scores in sensory evaluation and are at the most unfavorable level; the composite solid beverage of group 8 had a strong malt flavor, a remarkable sweet taste, and a tooth-sticking phenomenon, and 100 persons had an sensory evaluation result of 19 points, which was at the most unfavorable level.
Example 2: influence of yeast powder on composite solid beverage
The model numbers of the yeast powder related to the embodiment are YP106, YP101, YF100 and YF300, wherein the model numbers YP106 and YP101 are yeast powder and contain abundant polysaccharide, glucan and fiber; the YF100 and YF300 are yeast extracts, and the content of amino acids and peptides is high through operations such as enzymolysis and the like.
Weighing raw materials of the composite solid beverage according to the formula of group 1 in table 1, wherein YP106, YF100 and YF300 are respectively used for replacing yeast powder of YP101, fully and uniformly mixing to obtain a composite solid beverage sample, and carrying out sensory evaluation. The sensory evaluation results are shown in Table 3.
TABLE 3 influence of Yeast powder on composite solid beverage according to different preparation processes
Yeast powder type | Scoring |
YP106 | 27.5 |
YP101 | 27.5 |
YF100 | 20 |
|
20 |
YP106 and YP101 have similar mouthfeel and taste, and are not different; YF100 and YF300 have fresh taste and heavy flavor.
Example 3: effect of polypeptide content on composite solid beverage
Weighing the composite solid beverage materials according to the table 4, fully and uniformly mixing, granulating to obtain a composite solid beverage sample, and carrying out sensory evaluation on the composite solid beverage sample, wherein the sensory evaluation result is shown in the table 5.
TABLE 4 recipe (g/100g) of composite solid beverage of each group
TABLE 5 Effect of polypeptide content on composite solid beverages
Group of | Scoring |
Group 1 | 27.8 |
Group 2 | 20 |
Group 3 | 21.6 |
Group 4 | 14 |
The bovine bone collagen peptide and the rice protein peptide both belong to polypeptides, wherein the molecular weight of the bovine bone collagen peptide is 800-1200 daltons; the rice protein peptide has a molecular weight of less than 1000 daltons when the content of the rice protein peptide is higher than 60%, and the molecular weight of less than 2000 daltons when the content of the rice protein peptide is higher than 80%. Because the molecular weight of the polypeptide is generally small, the polypeptide has obvious bitter taste. Wherein the polypeptide contents of groups 1, 2, 3, and 4 were 20%, 22%, 28.5%, and 37%, respectively, as can be seen from the sensory evaluation in Table 7, the bitter taste could be adjusted by changing the contents of the malt extract and the sugar alcohol. Finally, the bitter taste can be covered to a large extent by adding 25% of malt extract.
Example 4: influence of particle size on composite solid beverage
Weighing the composite solid beverage material according to the formula of the group 1 in the table 1, fully and uniformly mixing, granulating at the granulation temperature of 50 ℃, and carrying out sensory solubility evaluation on the obtained composite solid beverage sample, wherein the solubility evaluation result is shown in the table 6.
TABLE 6 Effect of particle size on composite solid beverages
Number of meshes | Scoring |
20 to 30 mesh | 2.1 |
30 to 40 mesh | 3.7 |
Over 40 mesh | 4.8 |
Wherein, the oral liquid can be dissolved quickly in a mouth of 30-40 meshes, is not easy to generate flying powder and is not easy to choke, and can fully contact with the oral cavity by chewing, thereby reducing the peculiar smell of the oral cavity and ensuring the freshness of the oral cavity; the powder is thin and easy to choke when the powder is dissolved at the inlet of more than 40 meshes; the particles with the particle size of 20-30 meshes are thick, the dissolution is slow when the particles are brewed with water, and more precipitates exist; therefore, the composite solid beverage is selected to be 30-40 meshes.
Example 5: influence of malt extract on Water absorbability of composite solid beverage
Weighing the composite solid beverage material according to the formula of the group 1, the group 5 and the group 8, fully and uniformly mixing, granulating by 30-40 meshes to obtain a composite solid beverage sample, and placing the composite solid beverage sample in a stable environment at 25 ℃ for 48h for observation. Of these, groups 1 and 5 had very little powder caking, and group 8 was completely caking, and it can be concluded that malt extract had a large influence on the water absorption of the product.
Example 6: functional evaluation of composite solid beverage
The product was prepared according to group 1 formulation, commissioned by Yangzhou Huayu biology Co., Ltd and questionnaireed. The investigation report selected 100 volunteers to evaluate the improvement of the composite solid beverage. The 100 subjects had constipation symptoms of various degrees. As can be seen from figure 2, over 50% of volunteers have obvious improvement on constipation, gastrectasia and dyspepsia after taking the product for 1-2 weeks. Therefore, the composite prebiotics of the invention have positive effects and influences on the aspects of improving constipation, relieving gastrectasia and dyspepsia.
Comparative example 1:
the prebiotic solid beverage was prepared according to table 7 below, granulated by huayu biology ltd, mn, and subjected to questionnaire. The investigation report selected 100 volunteers to evaluate the improvement of the composite solid beverage. The 100 subjects had constipation symptoms of various degrees. The 100 subjects had constipation symptoms of various degrees. After the formula product is taken for about 1 week, 40% of volunteers have diarrhea phenomena of different degrees.
TABLE 7 solid beverage formulation
Raw materials | Content (g/5g) |
Inulin powder | 5 |
Comparative example 2:
the product is prepared according to the following table 8, a culture medium is prepared, the bifidobacterium bifidum bacterial liquid of 2 generations of activation is absorbed and respectively inoculated into 50 mu L of each culture medium in the table 8, the culture is carried out at the temperature of 37 +/-1 ℃, counting is carried out after 24h of culture, and the counting result is shown in the table 9.
TABLE 8 control group Medium
TABLE 9 count results
Serial number | Plate 1 | Plate 2 | Plate 3 | Average Total colony count (. times.10)8) |
Control group 1 | 8.5 | 7.8 | 8.1 | 8.13 |
Control group 2 | 10.1 | 10.5 | 9.7 | 10.1 |
Control group 3 | 10.2 | 10.4 | 10 | 10.2 |
Control group 4 | 9.7 | 9.8 | 10.1 | 9.87 |
Control group 5 | 10.3 | 9.6 | 10.1 | 10 |
Control group 6 | 11.3 | 12.0 | 12.1 | 11.8 |
Control group 7 | 13.5 | 14.1 | 13.6 | 13.73 |
As can be seen from Table 9, the total number of colonies of Bifidobacterium bifidum cultured in MRS-mupirocin lithium salt-modified medium was 8.1X 108(ii) a Using MRS-mupirocin lithium salt modified culture medium, respectively adding 6% fructo-oligosaccharide, 6% xylo-oligosaccharide, 6% galacto-oligosaccharide and 6% inulin, and respectively culturing Bifidobacterium bifidum with colony total number of 1.01 × 109、1.02×109、9.87×108、1.0×109Respectively improving the culture medium by 24.7%, 25.9%, 21.9% and 23.5%; MRS-mupirocin lithium salt modified medium was added to the formula of group 1 in Table 1 to culture Bifidobacterium bifidum with a total colony count of 1.37X 109Respectively increased by 69.1 percent compared with the original culture medium; the total number of colonies of Bifidobacterium bifidum cultured by using MRS-mupirocin lithium salt modified medium and adding 6% of inulin, 6% of galacto-oligosaccharide, 6% of xylo-oligosaccharide and 6% of fructo-oligosaccharide is 1.18 multiplied by 109Respectively improved by 45.6 percent compared with the original culture medium.
The product is prepared according to the following table 10, a culture medium is prepared, the bifidobacterium bifidum bacterial liquid activated for 2 generations is respectively absorbed and inoculated into 50 mu L of each culture medium in the table 10, the temperature is 37 +/-1 ℃, the counting is carried out after the culture is carried out for 24h, and the counting result is shown in the table 11.
TABLE 10 control group Medium
Adding | ||
Control group 1 | MRS | Without adding |
Control group 2 | MRS | 6% fructo-oligosaccharide |
Control group 3 | MRS | 6% xylo-oligosaccharide |
Control group 4 | MRS | 6% galacto-oligosaccharide |
Control group 5 | MRS | 6% of inulin |
Control group 6 | MRS | 6% of inulin, 6% of galacto-oligosaccharide, 6% of xylo-oligosaccharide and 6% of fructo-oligosaccharide |
Control group 7 | MRS | EXAMPLE 1 group 1 |
TABLE 11 results of counting
Serial number | Plate 1 | Plate 2 | Plate 3 | Average Total colony count (. times.10)9) |
Control group 1 | 1.3 | 1.03 | 1.2 | 1.18 |
Control group 2 | 1.4 | 1.51 | 1.52 | 1.47 |
Control group 3 | 1.43 | 1.51 | 1.5 | 1.48 |
Control group 4 | 1.49 | 1.48 | 1.5 | 1.49 |
Control group 5 | 1.47 | 1.49 | 1.51 | 1.49 |
Control group 6 | 1.65 | 1.68 | 1.67 | 1.67 |
Control group 7 | 1.80 | 1.81 | 1.80 | 1.80 |
As can be seen from Table 11, the total number of colonies of Lactobacillus casei cultured on MRS medium was 1.18X 109(ii) a Using MRS culture medium to add 6% fructo-oligosaccharide, 6% xylo-oligosaccharide, 6% galacto-oligosaccharide and 6% inulin, respectively, the total number of cultured lactobacillus casei colonies is 1.47 × 109、1.48×109、1.49×109、1.49×109Respectively improving the culture medium by 24.6 percent, 25.4 percent, 26.3 percent and 26.3 percent compared with the original culture medium; the lactobacillus casei is cultured by adding 6 percent of inulin, 6 percent of galacto-oligosaccharide, 6 percent of xylo-oligosaccharide and 6 percent of fructo-oligosaccharide into MRS culture medium, and the total number of colonies is 1.67 multiplied by 109Respectively increased by 41.5% compared with the original culture medium. MRS medium was used to add the formulation of group 1 of Table 1, and the total number of colonies of cultured Lactobacillus casei was 1.80X 109Respectively improved by 53.4 percent compared with the original culture medium.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (10)
1. The preparation method of the composite prebiotics solid beverage is characterized in that malt extract, protein peptide, sugar alcohol and prebiotics are used as raw materials, and the raw materials are mixed and granulated to obtain the composite solid beverage; the mass ratio of the malt extract to the protein peptide to the sugar alcohol to the prebiotics is 5: (3-5): (4-6): (4-6).
2. The method according to claim 1, wherein the protein peptide is a mixture of bovine bone collagen peptide and rice protein peptide.
3. The method according to claim 1, wherein the granulation temperature is 40 to 50 ℃.
4. The preparation method according to claim 1, wherein the granules are sieved with a 30-40 mesh sieve after granulation.
5. The production method according to claim 1, wherein the sugar alcohol is inulin, fructo-oligosaccharide, xylo-oligosaccharide and galacto-oligosaccharide; alternatively, the sugar alcohol is lactitol, xylitol, and erythritol.
6. The method of claim 5, further comprising yeast powder, wherein the yeast powder is rich in polysaccharides, glucan, and fiber.
7. The preparation method according to claim 6, wherein the mass ratio of the malt extract, the bovine bone collagen protein peptide, the yeast powder, the lactitol, the xylitol, the erythritol, the inulin, the xylo-oligosaccharide, the fructo-oligosaccharide, the galacto-oligosaccharide and the rice protein peptide is (5-50): (5-30): (6-30): (4-7.5): (4-10): (5-10): (5-8): (5.5-7): (5-7.5): (5-7.5): (5-11).
8. The preparation method according to claim 7, wherein the mass ratio of the malt extract, the bovine bone collagen peptide, the yeast powder, the lactitol, the xylitol, the erythritol, the inulin, the xylo-oligosaccharide, the fructo-oligosaccharide, the galacto-oligosaccharide and the rice protein peptide is 25: 15: 10: 7: 7: 7: 6: : 6: 6: 6: 5.
9. the composite prebiotic solid beverage prepared by the preparation method of any one of claims 1 to 8.
10. The use of the composite prebiotic solid beverage of claim 9 in the preparation of products for improving gastrointestinal function and preventing osteoporosis in humans.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911423148.5A CN111066991A (en) | 2019-12-31 | 2019-12-31 | Preparation method of composite prebiotics solid beverage for improving gastrointestinal tract function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911423148.5A CN111066991A (en) | 2019-12-31 | 2019-12-31 | Preparation method of composite prebiotics solid beverage for improving gastrointestinal tract function |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111066991A true CN111066991A (en) | 2020-04-28 |
Family
ID=70321443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911423148.5A Pending CN111066991A (en) | 2019-12-31 | 2019-12-31 | Preparation method of composite prebiotics solid beverage for improving gastrointestinal tract function |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111066991A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111718873A (en) * | 2020-06-19 | 2020-09-29 | 江南大学 | Lactobacillus fermentum with effect of relieving osteoporosis and application thereof |
CN112006289A (en) * | 2020-07-09 | 2020-12-01 | 陕西沐亿康美生物科技有限公司 | Compound food composition for assisting in regulating gastrointestinal tract and preparation method thereof |
CN113892656A (en) * | 2021-08-19 | 2022-01-07 | 广东绿宝堂健康科技有限公司 | Prebiotic composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101480491A (en) * | 2009-01-19 | 2009-07-15 | 湖南农业大学 | Bone collagen polypeptide composite solution for regulating intestines and preparation method thereof |
CN103750104A (en) * | 2014-01-16 | 2014-04-30 | 广东维美健健康食品有限公司 | Healthcare food for comprehensively improving disorder of spleen and stomach and intestinal tract and preparation method of healthcare food |
CN105011151A (en) * | 2015-05-25 | 2015-11-04 | 华隆(乳山)食品工业有限公司 | Composite prebiotics capable of regulating intestinal tract function of human body |
CN108354906A (en) * | 2018-05-25 | 2018-08-03 | 四川厚德医药科技有限公司 | A kind of medicinal oral instant dissipates and preparation method thereof |
CN109207543A (en) * | 2018-09-29 | 2019-01-15 | 内蒙古蒙肽生物工程有限公司 | A kind of ox bone collagen protein peptides and preparation method and purposes |
CN109757732A (en) * | 2019-03-01 | 2019-05-17 | 上海傅克化学科技有限公司 | A kind of oral liquid polypeptide powder and preparation method thereof |
-
2019
- 2019-12-31 CN CN201911423148.5A patent/CN111066991A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101480491A (en) * | 2009-01-19 | 2009-07-15 | 湖南农业大学 | Bone collagen polypeptide composite solution for regulating intestines and preparation method thereof |
CN103750104A (en) * | 2014-01-16 | 2014-04-30 | 广东维美健健康食品有限公司 | Healthcare food for comprehensively improving disorder of spleen and stomach and intestinal tract and preparation method of healthcare food |
CN105011151A (en) * | 2015-05-25 | 2015-11-04 | 华隆(乳山)食品工业有限公司 | Composite prebiotics capable of regulating intestinal tract function of human body |
CN108354906A (en) * | 2018-05-25 | 2018-08-03 | 四川厚德医药科技有限公司 | A kind of medicinal oral instant dissipates and preparation method thereof |
CN109207543A (en) * | 2018-09-29 | 2019-01-15 | 内蒙古蒙肽生物工程有限公司 | A kind of ox bone collagen protein peptides and preparation method and purposes |
CN109757732A (en) * | 2019-03-01 | 2019-05-17 | 上海傅克化学科技有限公司 | A kind of oral liquid polypeptide powder and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
后藤利夫: "《肠道清洁书》", 31 May 2009, 南海出版社 * |
齐玉梅: "《特殊医学用途配方食品 临床应用参考目录》", 30 August 2017, 中国医药科技出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111718873A (en) * | 2020-06-19 | 2020-09-29 | 江南大学 | Lactobacillus fermentum with effect of relieving osteoporosis and application thereof |
CN112006289A (en) * | 2020-07-09 | 2020-12-01 | 陕西沐亿康美生物科技有限公司 | Compound food composition for assisting in regulating gastrointestinal tract and preparation method thereof |
CN113892656A (en) * | 2021-08-19 | 2022-01-07 | 广东绿宝堂健康科技有限公司 | Prebiotic composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105146614B (en) | A kind of functional calcium fruit ferment, enzyme beverage and its production method | |
CN106619743A (en) | Probiotic solid drink with hypoglycaemic effect and preparation method of probiotic solid drink | |
CN104758318B (en) | A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate | |
CN108991327A (en) | A kind of probiotics solid beverage and preparation method thereof | |
CN111066991A (en) | Preparation method of composite prebiotics solid beverage for improving gastrointestinal tract function | |
US20140314719A1 (en) | IBS Treatment | |
CN108753677A (en) | A kind of cultural method of probiotics and its application | |
CN111227261A (en) | Prebiotic composition and application thereof | |
JP2816726B2 (en) | Composition for improving intestinal environment | |
CN112970990A (en) | Probiotic solid beverage with weight-losing and lipid-lowering effects and preparation process thereof | |
CN109315769A (en) | It is a kind of for improving the composition and preparation method thereof of human body enteral environment | |
CN113974043A (en) | Prebiotics solid beverage and preparation method thereof | |
WO2019112053A1 (en) | Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria | |
JP6163619B1 (en) | Compositions and methods for improving the balance of gut microbiota | |
CN116634889A (en) | Protein digestion and amino acid bioavailability by probiotic strains | |
CN111065274A (en) | Fermented milk for promoting increase of amino acid concentration in blood | |
EP2780023B1 (en) | Ibs treatment with probiotics | |
KR102000170B1 (en) | Food compositions for reducing body fat and improving intestinal function | |
CN106465830A (en) | Daily type dietary fiber solid beverage and preparation method thereof | |
JP2006182654A (en) | Body fat accumulation suppressing or reducing agent | |
JP2010155789A (en) | Hepatic function disorder-improving agent | |
JP7396798B2 (en) | Composition for promoting intestinal butyrate production | |
TW202202160A (en) | Composition for facilitating defecation and uses thereof | |
CN111264739A (en) | Probiotic solid beverage and preparation method thereof | |
EP4249052A1 (en) | Composition for improving intestinal bacterial flora and composition for suppressing production of substances by intestinal putrefaction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200428 |
|
RJ01 | Rejection of invention patent application after publication |